Portugal, May 29 -- Portugal based ROCHE FARMACEUTICA QUIMICA, LDA. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Ocrelizumab Sc 920Mg/23Ml Sol Inj, To Lab Roche, For Ulsasi, For The Year 2025. The value of the contract is worth 94590900 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....